Type 5 Diabetes Officially Recognised at World Congress 2025 Dr. Bhumika Maikhuri17 April 2025 8:00 AM ISTA newly recognised form of diabetes-Type 5 diabetes-was officially announced this week at the World Congress of Diabetes 2025 in Bangkok by Prof Peter...
New Guidelines for Managing Obesity in Children: CMAJ Dr. Bhumika Maikhuri16 April 2025 8:15 AM ISTA new guideline to help health care providers manage obesity in children and adolescents takes a patient-centred approach, emphasizing behavioural and...
Could Skipping Carbohydrates Be as Effective as Skipping Meals? Study Sheds Light Dr. Bhumika Maikhuri16 April 2025 8:00 AM ISTReducing carbohydrate intake even without cutting overall calories may deliver the same metabolic benefits as intermittent fasting, according to new...
Study Reveals Building Muscle Strength Could Lower Type 2 Diabetes Risk by Over 40 Percent Dr. Bhumika Maikhuri14 April 2025 8:30 AM ISTA new study has found that higher muscle strength was associated with over 40% lower risk of T2D, regardless of genetic susceptibility to T2D. The...
Could Eating Only During Daytime Reduce Heart Risk Associated with Shift Work? Study Sheds Light Dr. Bhumika Maikhuri11 April 2025 8:00 AM ISTA new study suggests that eating only during the daytime could help people avoid the health risks associated with shift work. Results are published in...
Severe Obesity Tied to Increased Risk of 16 Common Health Conditions: Study Dr. Bhumika Maikhuri9 April 2025 8:00 AM ISTA new study has found that obesity, particularly severe obesity, is strongly associated with the incidence of 16 common health outcomes. Associations...
Right Turn Show- Exploring Dapagliflozin Beyond Glycemic Benefits Deeksha Bhandari8 April 2025 12:34 PM ISTIn the last episode, we explored the role of Dapagliflozin in specialty care settings. Moving forward, this episode delves into Dapagliflozin Beyond...
USV Launches Empagliflozin Range Under Xenia Brand Deeksha Bhandari2 April 2025 12:23 PM ISTUSV Pvt. Ltd., a leader in diabetes care, has announced the launch of its Xenia brand range in India, following the patent expiry of Empagliflozin. ...
Smartwatches Revolutionize Diabetes Management Through Exercise Tracking: Study Finds Dr. Bhumika Maikhuri31 March 2025 8:00 AM ISTWearable mobile health technology could help people with Type 2 Diabetes (T2D) to stick to exercise regimes that help them to keep the condition under...
Study Reveals Calorie-Free Sweeteners May Confuse Brain's Appetite Signals Dr. Bhumika Maikhuri29 March 2025 8:15 AM ISTCompared to sugar, consuming sucralose a widely used sugar substitute increases activity in the hypothalamus, a brain region that regulates appetite...
USV Expands Diabetes Portfolio with Cost-Effective Liralin-EP in India Deeksha Bhandari22 March 2025 1:00 PM ISTUSV Pvt. Ltd., launches the Liralin EP a combination of Linagliptin & Empagliflozin at just Rs 12.90 per tablet for strengthening it's affordable...
Continuous Glucose Monitors Revolutionize Diabetic Ketoacidosis Management: Study Reveals Dr. Garima Soni21 March 2025 8:00 AM ISTDiabetic ketoacidosis is a common severe complication of diabetes, which develops when the body can't produce enough insulin.During DKA the body...
